These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 11650173)

  • 21. The FDA's final regulations: IRBs and medical devices.
    Holder AR
    IRB; 1980; 2(6):1-4. PubMed ID: 11661803
    [No Abstract]   [Full Text] [Related]  

  • 22. IRB review of adverse events in investigational drug studies.
    Prentice ED; Gordon B
    IRB; 1997; 19(6):1-4. PubMed ID: 11656910
    [No Abstract]   [Full Text] [Related]  

  • 23. Government regulation of scientific research.
    Robertson JA
    Jurimetrics; 1979; 19(4):301-38. PubMed ID: 11651670
    [No Abstract]   [Full Text] [Related]  

  • 24. OPRR and FDA propose revised expedited review categories.
    McGough H
    IRB; 1998; 20(1):9, 11. PubMed ID: 11655326
    [No Abstract]   [Full Text] [Related]  

  • 25. Revising human subjects policy: an example of consensual decision-making.
    Cohen JM; Hedberg WB
    J Soc Res Adm; 1984; 15(4):29-34. PubMed ID: 11649707
    [No Abstract]   [Full Text] [Related]  

  • 26. The history of institutional review boards.
    Sherman M; Van Vleet JD
    Regul Aff J; 1991; 3():615-27. PubMed ID: 11651491
    [No Abstract]   [Full Text] [Related]  

  • 27. Censoring research.
    De Sola Pool I
    Society; 1980; 18(1):39-40. PubMed ID: 11661972
    [No Abstract]   [Full Text] [Related]  

  • 28. Reflections on the FDA's intraocular lens regulations.
    Worthen DM
    IRB; 1980 Apr; 2(4):1-3. PubMed ID: 11661783
    [No Abstract]   [Full Text] [Related]  

  • 29. Two rules on expedited IRB reviews are final.
    Maloney DM
    Hum Res Rep; 1999 Jan; 14(1):3. PubMed ID: 11657557
    [No Abstract]   [Full Text] [Related]  

  • 30. Bill of rights for research subjects.
    Prentice ED; Reitemeier PJ; Antonson DL; Kelso TK; Jameton A
    IRB; 1993; 15(2):7-9. PubMed ID: 11651568
    [No Abstract]   [Full Text] [Related]  

  • 31. Increased review responsibilities for Australian institutional ethics committees.
    Darvall L
    IRB; 1995; 17(1):9. PubMed ID: 11653062
    [No Abstract]   [Full Text] [Related]  

  • 32. Can (or should) the IRB assume the FDA's functions at early stages of the IND process?
    Levine RJ
    IRB; 1981 Dec; 3(10):4-5. PubMed ID: 11649414
    [No Abstract]   [Full Text] [Related]  

  • 33. Federal report says protection of human subjects is threatened by numerous factors.
    Maloney DM
    Hum Res Rep; 1996 May; 11(5):1-3. PubMed ID: 11654438
    [No Abstract]   [Full Text] [Related]  

  • 34. Government regulation of research.
    Seiler LH; Murtha JM
    Society; 1980; 18(1):23-31. PubMed ID: 11661970
    [No Abstract]   [Full Text] [Related]  

  • 35. The changing clinical trials scene: the role of the IRB.
    Mitchell SC; Steingrub J
    IRB; 1988; 10(4):1-5. PubMed ID: 11650078
    [No Abstract]   [Full Text] [Related]  

  • 36. Protection of human subjects; informed consent; standards for institutional review boards for clinical investigations; and clinical investigations which may be reviewed through expedited review procedures.
    U.S. Food and Drug Administration
    Fed Regist; 1981 Jan; 46(17):8942-80. PubMed ID: 11658611
    [No Abstract]   [Full Text] [Related]  

  • 37. Research compliance changes will affect rules on protection of human subjects.
    Maloney DM
    Hum Res Rep; 1999 May; 14(5):1-2. PubMed ID: 11657776
    [No Abstract]   [Full Text] [Related]  

  • 38. U.S. halts research on humans at Duke: university can't ensure safety, probers find.
    Weiss R
    Washington Post; 1999 May; ():A1, A20. PubMed ID: 11647726
    [No Abstract]   [Full Text] [Related]  

  • 39. The regulation of biomedical research experimentation in Canada: developing an effective apparatus for the implementation of ethical principles in a scientific milieu.
    Verdun-Jones S; Weisstub DN
    Ottawa Law Rev; 1996-1997; 28(2):297-341. PubMed ID: 11657290
    [No Abstract]   [Full Text] [Related]  

  • 40. FDA may "pull the plug" on consent waiver.
    Ault A
    Lancet; 1997 Oct; 350(9084):1084. PubMed ID: 11655169
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.